UK has become the first country to license a vaccine against Covid-19. Pfizer’s vaccine had a 95% efficacy rate from their clinical trials and it has now been authorised for emergency use by the Medicines and Healthcare Products Regulatory Authority (MHRA). The MHRA in UK was given the power to approve the vaccine by the government under special regulations. The vaccine will be available in Britain as early as next week, according to a government statement.
Britain’s vaccine committee will decide which priority groups will get the first shot such as health care staff and workers, and people who are in high-risk of contracting the virus. However, it is not much news to cheer for India as the vaccine would not be available in India because Pfizer’s vaccine require an ultra-cold chain of minus 70 degree, currently India has no such facilities available.
There could also be an outflow of money of Foreign Institutional Investors from India to European markets. So be cautious while entering into trades. To know more about the stocks that could gain from the approval of vaccine in India, click here.